Director Strategy Pricing Management; Pharma Biotech

Location:

Onsite – Boston (Seaport), MA – Remote work is not offered with this role.

The Director, Strategic Pricing Management will shape US pricing strategies for pipeline and in-line products across Alexion’s rare disease portfolio. Based in Boston Seaport, you will report to the Executive Director, US Strategic Contracting & Pricing and serve as a senior advisor on pricing decisions that balance patient access, payer value, sustainable revenue, and long-term business performance.

Alexion’s robust rare disease pipeline, global reach, and evolving launch priorities create a meaningful opportunity to shape pricing strategy at a critical time. The US pricing environment is also changing quickly, with Most-Favored-Nation policy activity and broader pricing reforms increasing pressure on launch assumptions, payer value, access strategy, and long-term revenue planning. This leader will help translate that external complexity into practical, evidence-based pricing recommendations for the future.

• Developing US list pricing strategies for pipeline assets and price evolution strategies for in-line products.
• Assessing pricing impacts on patient access, gross-to-net, ASP, government pricing, and net revenue.
• Partnering with Global Market Access, HEOR, Contracting, Finance, Commercial, and Marketing teams to support launch and in-line pricing decisions.
• Evaluating value-based agreement opportunities and other innovative pricing approaches.
• Creating clear recommendations for senior leaders and influencing decisions across cross-functional and global forums.

• Bachelor's degree or equivalent experience in life sciences, business, finance, economics, or a related field.
• At least 7 years of relevant experience in biopharma pricing, market access, strategic contracting, commercial strategy, HEOR, consulting, or a related area.
• US pricing strategy experience, including launch, indication expansion, portfolio, or in-line pricing work.
• Strong understanding of the US payer, provider, reimbursement, and drug pricing landscape.
• Experience communicating complex analysis and recommendations to senior leaders.
• Strong analytical, strategic thinking, influencing, project management, and problem-solving skills.
• Advanced Microsoft Excel skills, including Pivot Tables, scenario analysis, and financial modeling.
• Ability to travel up to 10% overnight.

• Advanced degree, such as a master's, MBA, PhD, JD, or Pharm
  
  D.
• 10+ years of relevant biopharma experience, including product launch experience.
• Experience pricing rare disease or specialty therapies with complex reimbursement dynamics.
• Advanced pricing or revenue analytics experience, including GTN forecasting, price-volume analysis, government pricing assessments, or value-based agreement modeling.
• Practical experience using AI-enabled tools to improve pricing research, scenario planning, workflow efficiency, insight generation, or decision support.
• Executive presence and the ability to build alignment, challenge assumptions constructively, and influence senior and global stakeholders.

• The annual base pay for this position ranges from $215,000 - $250,678 USD Annual.
• Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours.
• Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience.
• In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles), to receive a retirement contribution…